These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26680638)

  • 41. Effect of a 2% topical chamomile application for treating burning mouth syndrome: a controlled clinical trial.
    Valenzuela S; Pons-Fuster A; López-Jornet P
    J Oral Pathol Med; 2016 Aug; 45(7):528-33. PubMed ID: 26694632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Challenge in the diagnosis, evaluation, and management of burning mouth sensation: A retrospective cohort study.
    Wu S; Zhang W; Wang X; He C; Yan Z
    J Am Dent Assoc; 2023 May; 154(5):436-444. PubMed ID: 36167586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A possible therapeutic solution for stomatodynia (burning mouth syndrome).
    Woda A; Navez ML; Picard P; Gremeau C; Pichard-Leandri E
    J Orofac Pain; 1998; 12(4):272-8. PubMed ID: 10425973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study.
    Petruzzi M; Lauritano D; De Benedittis M; Baldoni M; Serpico R
    J Oral Pathol Med; 2004 Feb; 33(2):111-4. PubMed ID: 14720197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of alpha-lipoic acid in patients with burning mouth syndrome compared to that of placebo or other interventions: a systematic review with meta-analyses.
    Christy J; Noorani S; Sy F; Al-Eryani K; Enciso R
    J Dent Anesth Pain Med; 2022 Oct; 22(5):323-338. PubMed ID: 36246031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of parafunctional habit control and topical lubricant on discomforts associated with burning mouth syndrome (BMS).
    Kho HS; Lee JS; Lee EJ; Lee JY
    Arch Gerontol Geriatr; 2010; 51(1):95-9. PubMed ID: 19775760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Burning mouth syndrome: a discussion of a complex pathology.
    Zur E
    Int J Pharm Compd; 2012; 16(3):196-205. PubMed ID: 23050296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical clonazepam in stomatodynia: a randomised placebo-controlled study.
    Gremeau-Richard C; Woda A; Navez ML; Attal N; Bouhassira D; Gagnieu MC; Laluque JF; Picard P; Pionchon P; Tubert S
    Pain; 2004 Mar; 108(1-2):51-7. PubMed ID: 15109507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Burning mouth syndrome: Identification, diagnosis, and treatment.
    Rivinius C
    J Am Acad Nurse Pract; 2009 Aug; 21(8):423-9. PubMed ID: 19689438
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Burning mouth syndrome: a review and update.
    Silvestre FJ; Silvestre-Rangil J; López-Jornet P
    Rev Neurol; 2015 May; 60(10):457-63. PubMed ID: 25952601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of burning mouth syndrome: systematic review and management recommendations.
    Patton LL; Siegel MA; Benoliel R; De Laat A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S39.e1-13. PubMed ID: 17379153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of treatment outcome in burning mouth syndrome patients using machine learning based on clinical data.
    Kim MJ; Kim PJ; Kim HG; Kho HS
    Sci Rep; 2021 Jul; 11(1):15396. PubMed ID: 34321575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome predictors of initial treatment with topical lubricant and parafunctional habit control in burning mouth syndrome (BMS).
    Ko JY; Park IH; Park HK; Kho HS
    Arch Gerontol Geriatr; 2011; 53(3):263-9. PubMed ID: 21075463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review.
    List T; Axelsson S; Leijon G
    J Orofac Pain; 2003; 17(4):301-10. PubMed ID: 14737874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. World Workshop on Oral Medicine VII: Burning mouth syndrome: A systematic review of disease definitions and diagnostic criteria utilized in randomized clinical trials.
    Ariyawardana A; Chmieliauskaite M; Farag AM; Albuquerque R; Forssell H; Nasri-Heir C; Klasser GD; Sardella A; Mignogna MD; Ingram M; Carlson CR; Miller CS
    Oral Dis; 2019 Jun; 25 Suppl 1():141-156. PubMed ID: 30785661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of moclobemide in burning mouth syndrome: a nonrandomized, open-label study.
    Pekiner FN; Gumru B; Ozbayrak S
    J Orofac Pain; 2008; 22(2):146-52. PubMed ID: 18548844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. WWOM VII: Effectiveness of topical interventions in the management of burning mouth syndrome: A systematic review.
    Goncalves S; Carey B; Farag AM; Kuten-Shorrer M; Natto ZS; Ariyawardana A; Mejia LM; Chmieliauskaite M; Miller CS; Ingram M; Nasri-Heir C; Sardella A; Carlson CR; Klasser GD; O'Neill F; Albuquerque R
    Oral Dis; 2023 Nov; 29(8):3016-3033. PubMed ID: 35781729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response to Treatment with Melatonin and Clonazepam versus Placebo in Patients with Burning Mouth Syndrome.
    Castillo-Felipe C; Tvarijonaviciute A; López-Arjona M; Pardo-Marin L; Pons-Fuster E; López-Jornet P
    J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Placebo effect in burning mouth syndrome: a systematic review.
    Kuten-Shorrer M; Kelley JM; Sonis ST; Treister NS
    Oral Dis; 2014 Apr; 20(3):e1-6. PubMed ID: 24164777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of clonazepam mouthwash on the symptomatology of burning mouth syndrome: an open pilot study.
    de Castro LA; Ribeiro-Rotta RF
    Pain Med; 2014 Dec; 15(12):2164-5. PubMed ID: 25287613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.